Ayala Pharmaceuticals Inc (ADXS)

[rmarc]

Head & neck cancer news:


"Shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) were 13.3% higher as of 11:12 a.m. EDT on Tuesday. The clinical-stage biotech announced the publication of results in Clinical Cancer Research, a major cancer journal, from a study of MEDI0457.

The data published in the journal focused on one patient in the study who experienced full remission from head and neck cancer after being treated by MEDI0457 followed by treatment with a PD-1 checkpoint inhibitor -- a type of cancer immunotherapy. This complete response by one patient has been sustained for more than two years."
Not good news for ADXS shareholders as con man Ken Berlin failed, just as I posted he would, to close a cash deal for ADXS HOT head & neck which is based on the still totally unproved ADXS "LM Technology" after over seven years of FDA trials. BP did not get duped by Berlin's con game.